The mechanisms at which these ameliorating effects are achieved may be via GLUT-4, IRS-1, PI3K and AKT gene upregulation which may probably enhance GLUT-4 translocation, reduce insulin resistance and induce PI3K/AKT signalling pathway (Fig. 9). The gene discussed is SLC2A4; the disease is Insulin resistance.